{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:24:44Z","timestamp":1792016684739,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"17-18","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["RO1NS041674"],"award-info":[{"award-number":["RO1NS041674"]}]},{"name":"NIH","award":["R21NS049623"],"award-info":[{"award-number":["R21NS049623"]}]},{"name":"5U01NS041071"},{"name":"5R25GM059994"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.lfs.2011.08.008","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T21:28:28Z","timestamp":1314307708000},"page":"638-643","source":"Crossref","is-referenced-by-count":20,"title":["L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"89","author":[{"given":"Jennifer M.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladson","family":"Muthian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marquitta","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clivel","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2011.08.008_bb0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cger.2006.06.003","article-title":"Parkinson's disease: background, diagnosis, and initial management","volume":"22","author":"Albin","year":"2006","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.lfs.2011.08.008_bb0010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1212\/01.WNL.0000052681.28286.52","article-title":"Initial agonist treatment of Parkinson disease: a critique","volume":"60","author":"Albin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2011.08.008_bb0015","unstructured":"Alvord EC. The pathology of Parkinsonism. II. An interpretation with special reference to other changes in the aging brain. Contemp Neurol Ser 1971;8:131\u201361. In: Minckler J, editor. p 1152\u20131161."},{"key":"10.1016\/j.lfs.2011.08.008_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00969090","article-title":"The effects of L-DOPA on the activity of methione adenosyltransferase: relevance to L-DOPA therapy and tolerance","volume":"18","author":"Benson","year":"1993","journal-title":"Neurochem Res"},{"key":"10.1016\/j.lfs.2011.08.008_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(94)90534-7","article-title":"Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons in the substantia nigra","volume":"668","author":"Bing","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2011.08.008_bb0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nbd.2007.08.010","article-title":"Intrastriatal inhibition of aromatic amino acid decarboxylase prevents L-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats","volume":"29","author":"Buck","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.lfs.2011.08.008_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1476-5381.1969.tb09522.x","article-title":"The metabolism of orally administered L-DOPA in Parkinsonism","volume":"37","author":"Calne","year":"1969","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2011.08.008_bb0055","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.conb.2008.01.004","article-title":"Advances in understanding L-DOPA-induced dyskinesia","volume":"17","author":"Cenci","year":"2007","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.lfs.2011.08.008_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199855001-00001","article-title":"The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease","volume":"55","author":"Chase","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2011.08.008_bb0070","first-page":"181","article-title":"Striatal dopaminoceptive system changes and motor response complications in L-dopa-treated patients with advanced Parkinson's disease","volume":"60","author":"Chase","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1016\/j.lfs.2011.08.008_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-1331.1999.610001.x","article-title":"Motor fluctuations in Parkinson's disease: pathophysiology and treatment","volume":"6","author":"Colosimo","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lfs.2011.08.008_bb0080","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0024-3205(87)90030-0","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde","volume":"40","author":"Corsini","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2011.08.008_bb0090","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1212\/WNL.42.4.726","article-title":"Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology","volume":"42","author":"Edwards","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2011.08.008_bb0100","first-page":"266","article-title":"Pathology of parkinsonism","volume":"24","author":"Forno","year":"1996","journal-title":"J Neurosurg"},{"key":"10.1016\/j.lfs.2011.08.008_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1600-0773.1990.tb00833.x","article-title":"MPTP-induced hypoactivity in mice: reversal by L-DOPA","volume":"67","author":"Fredriksson","year":"1990","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.lfs.2011.08.008_bb0110","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","author":"Goodman","year":"2006"},{"key":"10.1016\/j.lfs.2011.08.008_bb0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1755-5949.2008.00058.x","article-title":"Enhancing aromatic l-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease","volume":"14","author":"Hadjiconstantinou","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.lfs.2011.08.008_bb0120","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1471-4159.1993.tb03503.x","article-title":"Aromatic l-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors","volume":"60","author":"Hadjiconstantinou","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.lfs.2011.08.008_bb0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.lfs.2011.08.008_bb0135","series-title":"Parkinson's disease and movement disorders","author":"Jankovic","year":"2007"},{"key":"10.1016\/j.lfs.2011.08.008_bb0140","series-title":"Society for neuroscience abstracts","article-title":"L-DOPA treatment modulates the expression and activity of l-aromatic amino acid decarboxylase through the production of dopamine","author":"King","year":"2008"},{"key":"10.1016\/j.lfs.2011.08.008_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-2999(74)90072-7","article-title":"Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice","volume":"26","author":"Kuschinsky","year":"1974","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2011.08.008_bb0150","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1476-5381.1973.tb08211.x","article-title":"Effect of chronic L-DOPA administration of catecholamine metabolism in the rat","volume":"47","author":"Lancaster","year":"1973","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2011.08.008_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11064-007-9442-6","article-title":"The role of 3-O-methyldopa in the side effects of L-DOPA","volume":"33","author":"Lee","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.lfs.2011.08.008_bb0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.410200212","article-title":"Inhibition of l-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography","volume":"20","author":"Leenders","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lfs.2011.08.008_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2011.08.008_bb0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.bi.40.070171.002341","article-title":"Biochemistry of catecholamines","volume":"40","author":"Molinoff","year":"1971","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.lfs.2011.08.008_bb0180","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ana.410220406","article-title":"Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies","volume":"22","author":"Mouradian","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lfs.2011.08.008_bb0205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0304-3940(91)90941-L","article-title":"Destruction of norepephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-DOPA","volume":"123","author":"Nishi","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.lfs.2011.08.008_bb0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(87)90120-X","article-title":"Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra","volume":"403","author":"Ricaurte","year":"1987","journal-title":"Brain Res"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2011.08.008_bb0220","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S1353-8020(09)70005-7","article-title":"The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease","volume":"15","author":"Stocchi","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2011.08.008_bb0225","doi-asserted-by":"crossref","first-page":"S599","DOI":"10.1002\/mds.22052","article-title":"Treatment of levodopa-induced motor complications","author":"Stocchi","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.lfs.2011.08.008_bb0230","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(90)91656-2","article-title":"Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL\/6 mice: a model for Parkinson's disease","volume":"528","author":"Sundstr\u00f6m","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2011.08.008_bb0235","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2011.08.008_bb0245","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(87)90033-3","article-title":"Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice","volume":"402","author":"Willis","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2011.08.008_bb0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exnr.2001.7726","article-title":"L-DOPA upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase","volume":"171","author":"Zhao","year":"2001","journal-title":"Exp Neurol"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051100405X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051100405X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T23:22:46Z","timestamp":1638400966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432051100405X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":36,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S002432051100405X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2011.08.008","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}